Page 2 - சரோ டி ரூ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சரோ டி ரூ. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சரோ டி ரூ Today - Breaking & Trending Today

UK supermarkets to phase out "Forever Chemicals", PFAS, from food packaging Envirotech Online

New details published by environmental charity, Fidra, show 5 out of 10 major UK supermarkets are taking voluntary action to reduce or remove PFAS from own brand food packaging, 2 aiming to be PFAS-free by the end of 2021. Click to read more. ....

East Lothian , United Kingdom , Poly Fluoroalkyl Substances , United Kingdom Government , United Kingdom Wide , கிழக்கு லோதியன் , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது கிஂக்டம் அரசு , ஒன்றுபட்டது கிஂக்டம் பரந்த ,

What Are the Clinical Applications of Mass Spectrometry?


May 24 2021
Since German physicist Wilhelm Wien first laid the foundations of mass spectroscopy in the late 1800s, the analytical technique has evolved in leaps and bounds. Today, using ionisation to sort ions according to mass-to-charge ratio is one of the most reliable and accurate ways to identify chemical substances.
The analytical technique is used across a range of fields, including clinical research, pharmacology, food quality control, carbon dating and more. Want to know more about the clinical applications of mass spectrometry? Below, we explore some of the key areas where mass spectrometry is used to identify chemical substances and accelerate modern research. ....

Wilhelm Wien , Performance Liquid Chromatography ,

Emmes snaps up U.K.'s Orphan Reach, boosting its rare disease offerings


(Pixabay)
U.S.-based contract research organization Emmes is starting a mini buying spree as it buys up fellow CRO Orphan Reach.
This U.S.-based company, with offices in Ireland, Germany, India and Canada, will boost Emmes’ geographic footprint as well as deepen its offering in rare diseases. Financial details of the deal were not released.
This is also Emmes second acquisition in the past four months, coming after it snapped up Neox s.r.o., a European-based CRO.
“Our acquisition of Orphan Reach will accelerate our growth, establishing us as an industry leader in clinical research for orphan and rare diseases,” said Emmes’ CEO Christine Dingivan, M.D., who became its leader in the fall.   ....

Christine Dingivan , Thomas Ogorka , Orphan Reach , United Kingdom , Contract Research Organizations , Mergers And Acquisitions , Rare Diseases , ஆர்ஃபந் ரீச் , ஒன்றுபட்டது கிஂக்டம் , ஒப்பந்த ஆராய்ச்சி ஆர்கநைஸேஶந்ஸ் ,